On Monday, Twist Bioscience Corp (NASDAQ: TWST) opened lower -4.40% from the last session, before settling in for the closing price of $38.82. Price fluctuations for TWST have ranged from $27.41 to $60.90 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 42.89% over the past five years. Company’s average yearly earnings per share was noted 43.45% at the time writing. With a float of $56.36 million, this company’s outstanding shares have now reached $59.58 million.
Let’s look at the performance matrix of the company that is accounted for 923 employees. In terms of profitability, gross margin is 44.59%, operating margin of -63.15%, and the pretax margin is -59.59%.
Twist Bioscience Corp (TWST) Insider Updates
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Twist Bioscience Corp is 5.52%, while institutional ownership is 105.72%. The most recent insider transaction that took place on Feb 24 ’25, was worth 38,209. In this transaction Chief Accounting Officer of this company sold 916 shares at a rate of $41.71, taking the stock ownership to the 51,675 shares. Before that another transaction happened on Feb 21 ’25, when Company’s Chief Accounting Officer sold 267 for $44.18, making the entire transaction worth $11,795. This insider now owns 52,591 shares in total.
Twist Bioscience Corp (TWST) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.55 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 43.45% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.54% during the next five years compared to 1.70% growth over the previous five years of trading.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
Check out the current performance indicators for Twist Bioscience Corp (TWST). In the past quarter, the stock posted a quick ratio of 4.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.38, a number that is poised to hit -0.55 in the next quarter and is forecasted to reach -1.50 in one year’s time.
Technical Analysis of Twist Bioscience Corp (TWST)
Twist Bioscience Corp (NASDAQ: TWST) saw its 5-day average volume 1.08 million, a positive change from its year-to-date volume of 0.9 million. As of the previous 9 days, the stock’s Stochastic %D was 5.35%. Additionally, its Average True Range was 3.13.
During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 4.05%, which indicates a significant decrease from 5.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.82% in the past 14 days, which was lower than the 61.99% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $47.17, while its 200-day Moving Average is $46.69. Nevertheless, the first resistance level for the watch stands at $38.81 in the near term. At $40.50, the stock is likely to face the second major resistance level. The third major resistance level sits at $41.74. If the price goes on to break the first support level at $35.88, it is likely to go to the next support level at $34.64. Assuming the price breaks the second support level, the third support level stands at $32.95.
Twist Bioscience Corp (NASDAQ: TWST) Key Stats
There are currently 59,651K shares outstanding in the company with a market cap of 2.21 billion. Presently, the company’s annual sales total 312,970 K according to its annual income of -208,730 K. Last quarter, the company’s sales amounted to 88,710 K and its income totaled -31,590 K.
